Prohibits vaping in educational institutions; requires educational institutions to educate communities about health risks associated with vaping and post no-vaping signage on educational institution premises.
Authorizes certain persons to possess and administer epinephrine by use of an epinephrine auto-injector device upon completion of appropriate training; requires the department of health to establish a registry of the names of lay persons trained in the use of an epinephrine auto-injector device.
Requires a certified copy or certified transcript of a birth record, death record, certificate of marriage, or certificate of dissolution of marriage to be issued to the child, grandchild, or great-grandchild of a deceased person upon request; removes requirement for such individuals to obtain a court order for issuance of such records.
Prohibits Medicaid service providers from requiring prior authorization for antiretroviral prescription drugs for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).
Prohibits the sale of entertainment vapor products, or any vapor product that has bluetooth, wireless internet, or other internet connectivity, or the ability to play virtual games, play music, or display photos or other animations on the device.
Requires vehicles operated by public transit authorities to contain opioid antagonists and for public transit authorities to train employees on the proper use of opioid antagonists.
Allows schools and camps to implement a policy to administer over-the-counter medication to students and children attending such schools or camps upon written request by such students' and children's parents or guardians.
Permits an eligible individual's spouse or designated representative, parent, adult child or in-law relative to be a personal assistant under the consumer directed personal assistance program.
Enacts the "foreign drug transparency act"; requires the disclosure to a health plan, pharmacy and patient whether a prescription drug was manufactured or compounded in a foreign country; whether the prescription was approved by the federal food and drug administration foreign drug inspection program; requires the date of the last inspection of such prescription drug by the federal food and drug administration foreign drug inspection program; requires certain labelling on such drugs.